A multidisciplinary team of researchers is the first to show combining yeast-expression technology and a novel adjuvant formulation to produce a COVID-19 vaccine candidate is effective against SARS-COV-2 and promises to be ...
Jul 15, 2021
0
14
Cuba on Friday approved its home-grown Abdala vaccine for emergency use, the first Latin American coronavirus jab to reach this stage and a possible lifeline for a region trying to battle a killer pandemic with modest means.
Jul 9, 2021
0
2
The University of Oxford today started vaccinations of a novel HIV vaccine candidate as part of a Phase I clinical trial in the UK.
Jul 5, 2021
0
2
Results from the first trial of a new COVID-19 vaccine technology show no short-term safety concerns.
Jul 2, 2021
1
5
Clinical evaluation of three COVID-19 vaccine candidates in 2020-21 during a worldwide pandemic that killed or sickened millions was unprecedented in terms of urgency and scope. Responsibility for the safety, integrity and ...
Jun 15, 2021
0
5
A group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a protein-based vaccine candidate elicited ...
Jun 15, 2021
1
24
In the four decades since the first cases of what would come to be known as AIDS were documented, scientists have made huge strides in HIV treatment, transforming what was once a death sentence to a manageable condition.
Jun 7, 2021
0
12
A needle-free COVID-19 vaccination could be possible, with University of Queensland scientists successfully protecting mice from the virus by administering a US-developed vaccine candidate with a 'patch."
Jun 3, 2021
0
14
Scientists have identified a promising vaccine candidate for a parasitic disease that causes a chronic wasting disease in livestock animals across sub Saharan Africa.
May 27, 2021
0
8
Canada's Medicago and British pharmaceutical giant GlaxoSmithKline on Tuesday announced positive interim results for their COVID-19 vaccine candidate.
May 18, 2021
0
0
